News Conference News TCT 2025 ENCIRCLE: Good Results With Sapien M3 Transseptal TMVR Todd Neale October 27, 2025
News Conference News TCT 2025 Tendyne Safely Reduces MR in Patients With Severe Calcification: SUMMIT-MAC Yael L. Maxwell October 27, 2025
News Conference News TCT 2025 More Data on Tricuspid Valve Interventions Reassure, yet Questions Remain Yael L. Maxwell October 26, 2025
News Conference News TCT 2025 TTVR Remains Safe, Effective in Presence of CIED Leads Todd Neale October 25, 2025
News Conference News EACTS 2025 SAVR Bests TAVI in Patients With Highly Calcific Aortic Valves Yael L. Maxwell October 20, 2025
News Conference News ESC 2025 ESC/EACTS Release New Valvular Heart Disease Guidelines Yael L. Maxwell September 03, 2025
News Conference News NY Valves 2025 MitraClip Safe and Effective in Non-COAPT-Like Patients: EXPANDed Yael L. Maxwell July 03, 2025
News Conference News NY Valves 2025 Changes in Quality of Life Mirror TR Reductions After Tricuspid Procedures: Tri-QOL Yael L. Maxwell July 01, 2025
News Conference News NY Valves 2025 Prompt TAVI Benefits Asymptomatic AS Patients Regardless of Guideline Indication Todd Neale June 27, 2025
News Conference News NY Valves 2025 Failure of ‘Jailed’ CIED Leads Not Uncommon After TTVR: TRIPLACE Todd Neale June 27, 2025
News Conference News EuroPCR 2025 Myval Noninferior to Other THVs at 1 Year, but Questions Persist L.A. McKeown May 21, 2025
News Conference News EuroPCR 2025 Early TAVI Improves Prognosis in Asymptomatic AS No Matter the Extent of Cardiac Damage Yael L. Maxwell May 21, 2025
News Conference News SCAI 2025 Benefits of TAVI Before Symptom Onset Not Hindered by Age: EARLY TAVR L.A. McKeown May 02, 2025
News Conference News SCAI 2025 More Patient-Prosthesis Mismatch With TAVI in Women, but 5-Year Survival Unaffected L.A. McKeown May 02, 2025
News Conference News ACC 2025 EARLY TAVR: Delaying Valve Replacement Increases Risk of Poor Outcomes L.A. McKeown April 07, 2025
News Conference News ACC 2025 DETECT-AS: Alert System Increases AV Replacement in Eligible Patients Michael O'Riordan April 04, 2025
News Conference News ACC 2025 By 2 Years, Tricuspid TEER Reduces Hospitalizations for HF: TRILUMINATE Michael O'Riordan March 31, 2025
News Conference News ACC 2025 Dapagliflozin Works Well for High-Risk TAVI Patients With HF: DapaTAVI Caitlin E. Cox March 30, 2025
News Conference News CRT 2025 SMART: Small Aortic Annuli Still Fare Best With Self-Expandable Valves at 2 Years L.A. McKeown March 10, 2025
News Conference News THT 2025 Positive Results With Carillon Mitral Device Seen in Real-world Registries Todd Neale February 21, 2025